Evolent Health Inc Cl A Com (EVH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -534,510 | -105,379 | -84,515 | -64,618 | -61,623 |
| Depreciation Amortization | 528,449 | 81,280 | 52,125 | 26,449 | 126,715 |
| Income taxes - deferred | -2,982 | 57 | -570 | 295 | -2,989 |
| Accounts receivable | 73,703 | 7,364 | 55,925 | -15,815 | 32,062 |
| Accounts payable and accrued liabilities | 6,639 | 21,501 | 18,189 | 3,264 | 4,248 |
| Other Working Capital | -55,623 | -93,847 | -81,668 | -23,045 | -113,296 |
| Other Operating Activity | 23,167 | 79,067 | 14,745 | 78,035 | 33,648 |
| Operating Cash Flow | $38,843 | $-9,957 | $-25,769 | $4,565 | $18,765 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -34,088 | -26,327 | -17,365 | -8,595 | -24,893 |
| Net Acquisitions | -57,443 | -56,045 | -56,047 | -4,498 | -30,725 |
| Purchase Of Investment | -1,000 | -1,000 | -1,000 | N/A | -7,321 |
| Sale Of Investment | 986 | 986 | 788 | N/A | 7 |
| Other Investing Activity | 91,312 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $-233 | $-82,386 | $-73,624 | $-13,093 | $-62,932 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 408,047 | 389,740 | 221,000 | 221,000 | 58,576 |
| Debt Repayment | -342,984 | -229,255 | -62,500 | -62,500 | N/A |
| Common Stock Issued | N/A | -39,996 | N/A | N/A | 3,461 |
| Common Stock Repurchased | -39,996 | N/A | N/A | N/A | N/A |
| Dividend Paid | -11,127 | -11,127 | -9,198 | -4,577 | -20,085 |
| Other Financing Activity | -49,864 | -52,250 | -50,375 | -46,069 | -42,517 |
| Financing Cash Flow | $-35,924 | $57,112 | $98,927 | $107,854 | $-565 |
| Beginning Cash Position | 178,496 | 178,496 | 178,496 | 178,496 | 223,457 |
| End Cash Position | 180,696 | 143,004 | 177,970 | 277,845 | 178,496 |
| Net Cash Flow | $2,200 | $-35,492 | $-526 | $99,349 | $-44,961 |
| Free Cash Flow | |||||
| Operating Cash Flow | 38,843 | -9,957 | -25,769 | 4,565 | 18,765 |
| Capital Expenditure | -34,088 | -26,327 | -17,365 | -8,595 | -24,893 |
| Free Cash Flow | 4,755 | -36,284 | -43,134 | -4,030 | -6,128 |